These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6150183)

  • 1. Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
    Cowley AJ; Rowley JM; Stainer K; Hampton JR
    Lancet; 1984 Nov; 2(8412):1120-4. PubMed ID: 6150183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
    Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M
    Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
    Cowley AJ; Stainer K; Rowley JM; Hampton JR
    Br Heart J; 1986 Jan; 55(1):75-80. PubMed ID: 3947485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril therapy for heart failure. A placebo controlled study.
    Cowley AJ; Rowley JM; Stainer KL; Hampton JR
    Lancet; 1982 Oct; 2(8301):730-2. PubMed ID: 6125809
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study.
    Cowley AJ; Stainer K; Wynne RD; Rowley JM; Hampton JR
    Int J Cardiol; 1989 Sep; 24(3):311-6. PubMed ID: 2527829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle.
    Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG
    Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
    Kramer BL; Massie BM; Topic N
    Circulation; 1983 Apr; 67(4):807-16. PubMed ID: 6337741
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Kramer B; Topic N; Massie B
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the angiotensin converting enzyme inhibitor, enalapril, on exercise tolerance and abnormalities of limb blood flow and respiratory function in patients with severe heart failure.
    Cowley AJ; Rowley JM; Stainer K; Hampton JR
    Eur Heart J; 1993 Jul; 14(7):964-8. PubMed ID: 8375423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
    Sharpe DN; Coxon RJ
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril - an oral angiotensin-converting enzyme inhibitor in CHF.
    Chatterjee K; Rouleau JL; Parmley WW
    Acta Med Scand Suppl; 1981; 652():181-7. PubMed ID: 6800218
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: a double-blind, placebo-controlled, randomized trial.
    Borgi C; Magelli C; Costa FV; Magnani B; Ambrosioni E
    Clin Cardiol; 1990 May; 13(5):329-34. PubMed ID: 2189613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of captopril in the treatment of patients with severe forms of chronic heart failure].
    Irani RM
    Ter Arkh; 1986; 58(11):55-8. PubMed ID: 3547747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
    Chatterjee K; Rouleau JL; Parmley WW
    Br Heart J; 1982 Mar; 47(3):233-8. PubMed ID: 7037025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe circulatory insufficiency in congestive cardiomyopathy treated successfully with captopril].
    Manitius J; Gross E; Koprowski A; Wyrzykowski B
    Wiad Lek; 1984 Jul; 37(14):1105-8. PubMed ID: 6393590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.